The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells.

The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells.
复制标题

N端尾部与碳水化合物识别域协调介导galectin-3诱导的T细胞凋亡

DOI:
10.18632/oncotarget.17760
复制
发表时间:
2017-07-25
期刊:
影响因子:
--
通讯作者:
Tai G
Tai G
中科院分区:
其他
文献类型:
--
作者:
Xue H;Liu L;Zhao Z;Zhang Z;Guan Y;Cheng H;Zhou Y;Tai G

文献摘要

参考文献

相似文献

半乳糖凝集素-3是一种半乳糖凝集素,具有独特的柔性N-末端尾(NT),连接到保守的碳水化合物识别结构域(CRD)。半乳糖凝集素-3与肿瘤免疫耐受相关,并表现出诱导T细胞凋亡的能力。我们使用Jurkat,Jurkat E6-1和CEM T细胞系和人外周血单个核细胞(PBMC)来研究CRD和NT在诱导T细胞凋亡中的特异性作用。半乳糖凝集素-3触发持续的细胞外信号调节激酶(ERK)磷酸化,诱导细胞凋亡。ERK位于caspase-9的上游,独立地被活性氧(ROS)和蛋白激酶C(PKC)激活。前12个NT残基在凋亡中没有作用。残基13-68是激活ROS所必需的,但不激活PKC。然而,残基69-110是激活PKC所必需的。NT片段和NT特异性抗体拮抗全长半乳糖凝集素-3引发的细胞凋亡,进一步支持我们的研究结果。这些发现表明CRD和NT在诱导T细胞凋亡过程中起重要作用,这表明它们有可能作为逆转癌症免疫耐受的治疗靶点。
Galectin-3 is a galectin with a unique flexible N-terminal tail (NT) connected to the conserved carbohydrate recognition domain (CRD). Galectin-3 is associated with tumor immune tolerance and exhibits an ability to induce T cell apoptosis. We used Jurkat, Jurkat E6-1 and CEM T-cell lines and human peripheral blood mononuclear cells (PBMCs) to investigate the specific roles of the CRD and NT in inducing T cell apoptosis. Galectin-3 triggered sustained extracellular signal-regulated kinase (ERK) phosphorylation that induced apoptosis. ERK was situated upstream of caspase-9 and was independently activated by reactive oxygen species (ROS) and protein kinase C (PKC). The first twelve NT residues had no role in the apoptosis. Residues 13-68 were essential for activating ROS, but did not activate PKC. However, residues 69-110 were required for activation of PKC. An NT fragment and a NT-specific antibody antagonized the apoptosis triggered by full-length galectin-3 further supporting our findings. These findings indicate the CRD and NT play important roles during induction of T cell apoptosis, which suggests their potential as therapeutic targets for reversing cancer immune tolerance.
DOI: 10.1158/1078-0432.ccr-12-2940
发表时间: 2013-04-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Chen C;Duckworth CA;Zhao Q;Pritchard DM;Rhodes JM;Yu LG
通讯作者: Yu LG
DOI: 10.1038/cddis.2010.1
发表时间: 2010
影响因子: 9
作者:
通讯作者: --
DOI: 10.1074/jbc.c000405200
发表时间: 2000-10-06
影响因子: 4.8
作者:
Jiang, XJ;Wang, XD
通讯作者: Wang, XD
DOI: 10.1016/j.immuni.2008.01.011
发表时间: 2008-03-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Demotte, Nathalie;Stroobant, Vincent;van der Bruggen, Pierre
通讯作者: van der Bruggen, Pierre
DOI: 10.1074/jbc.m312697200
发表时间: 2004-08-13
影响因子: 4.8
作者:
Elad-Sfadia, G;Haklai, R;Kloog, Y
通讯作者: Kloog, Y